Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03286972 · ClinicalTrials.gov registry record
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 3
- Enrollment target
NCT03286972: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT03286972 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03286972 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate this new technology available at the University of Wisconsin Carbone Cancer Center in the setting of head and neck cancer radiation treatment planning. This study will also provide preliminary data critical to the development of multi-parametric, multi-modality quantitative imaging biomarkers and data analysis models for prediction of outcome in both tumors and normal tissue, which are essential for patient-specific adaptive therapy. All participants will undergo a diagnostic PET/CT and a Radiation Treatment Planning CT per SOC procedures. In addition, all participants will undergo an additional imaging set consisting of a PET/MRI. It is anticipated that most patients will undergo the PET/MRI on the same day as their PET/CT negating the need for a second injection of the FDG radioisotope used for SOC PET imaging. All patients will receive gadolinium contrast per SOC dosing guidelines for the MRI portion of the PET/MRI. Both SOC MMRI pulse sequences and investigational sequences will be utilized in this study.
Primary Outcome
Identify the percentage of head and neck cancer patients who are able to successfully complete or partially complete the PET/MRI examination. Responses to a 7 point Likert scale will be analyzed with a chi-squared test.
Interventions
- DEVICE PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2019-06-20 |
Why NCT03286972 stopped before completion
NCT03286972 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT03286972 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03286972 about?
NCT03286972 is a clinical study titled "PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning". The purpose of this study is to evaluate this new technology available at the University of Wisconsin Carbone Cancer Center in the setting of head and neck cancer radiation treatment planning. This study will also provide preliminary data critical to the development of multi-parametric, multi-modali...
What is the current status of trial NCT03286972?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2017-09-12. Estimated completion is 2019-06-20.
What interventions are being tested in trial NCT03286972?
The interventions under investigation include: PET/MRI (DEVICE).
Who is sponsoring clinical trial NCT03286972?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI